JFrog Ltd. Ordinary Shares vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? JFrog Ltd. Ordinary Shares trades at $98.2 (market cap $11.99B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 4.9× JFrog Ltd. Ordinary Shares's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while JFrog Ltd. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold JFrog Ltd. Ordinary Shares for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| FROG | TAK | |
|---|---|---|
Market Cap | $11.99B | $58.74B |
Volume | 1,116,446 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $104.03 | $19.05 |
52-Week Low | $34.75 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.18B | $86.65B |
Dividend Yield | — | 3.33% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →